| 000 | 01594 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250513112448.0 | ||
| 264 | 0 | _c19970619 | |
| 008 | 199706s 0 0 eng d | ||
| 022 | _a0264-410X | ||
| 024 | 7 |
_a10.1016/s0264-410x(96)00057-6 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aIorio, A M | |
| 245 | 0 | 0 |
_aImmunogenicity of influenza vaccine (1993-94 winter season) in HIV-seropositive and -seronegative ex-intravenous drug users. _h[electronic resource] |
| 260 |
_bVaccine _cJan 1997 |
||
| 300 |
_a97-102 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntibodies, Viral _xbiosynthesis |
| 650 | 0 | 4 | _aCD4 Lymphocyte Count |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHIV Antibodies _xblood |
| 650 | 0 | 4 |
_aHIV Core Protein p24 _xblood |
| 650 | 0 | 4 |
_aHIV Infections _xcomplications |
| 650 | 0 | 4 |
_aHIV Seronegativity _ximmunology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunization, Secondary |
| 650 | 0 | 4 |
_aInfluenza Vaccines _ximmunology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aSubstance Abuse, Intravenous _xcomplications |
| 700 | 1 | _aAlatri, A | |
| 700 | 1 | _aFrancisci, D | |
| 700 | 1 | _aPreziosi, R | |
| 700 | 1 | _aNeri, M | |
| 700 | 1 | _aDonatelli, I | |
| 700 | 1 | _aCastrucci, M R | |
| 700 | 1 | _aBiasio, L R | |
| 700 | 1 | _aTascini, C | |
| 700 | 1 | _aIapoce, R | |
| 700 | 1 | _aPierucci, P | |
| 700 | 1 | _aBaldelli, F | |
| 773 | 0 |
_tVaccine _gvol. 15 _gno. 1 _gp. 97-102 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0264-410x(96)00057-6 _zAvailable from publisher's website |
| 999 |
_c9030275 _d9030275 |
||